The Experts below are selected from a list of 50631 Experts worldwide ranked by ideXlab platform
Alessandro Liberati - One of the best experts on this subject based on the ideXlab platform.
-
“Meta-analysis: Statistical alchemy for the 21st century”: Discussion. A plea for a more balanced view of meta-analysis and systematic overviews of the effect of health care interventions
Journal of clinical epidemiology, 1995Co-Authors: Alessandro LiberatiAbstract:Abstract The paper discusses some of the most common criticisms to meta-analysis presented by Professor Feinstein in this Conference. As many of the points raised in his contributions are not new, a critique to them is presented in the context of the type of contribution given by systematic reviews (meta-analysis) to the analysis of the effects of health care interventions. After discussing some terminological issues, the paper challenges Feinsteins' arguments indicating that meta-analysis is inherently faulted on four grounds: (a) reproducibility, (b) precision, (c) suitable extrapolation, (d) fair comparison. Each point is discussed providing examples drawn from the published literature with a view to indicate that—despite their current limitations—systematic reviews are a necessary step to synthesize information, orient clinical research and help produce practice guidelines.
Mark Dicamillo - One of the best experts on this subject based on the ideXlab platform.
-
Release # 2017-04: While Feinstein receives high job marks, voters hold mixed views about whether a re-election bid would be good for the state. Age a factor to some. Governor Brown the leading Democrat for Senate if Feinstein chooses not to run.
2017Co-Authors: Mark DicamilloAbstract:University of California, Berkeley Institute of Governmental Studies 109 Moses Hall, #2370 Berkeley, CA 94720-2370 Tel: 510-642-1473 Fax: 510-642-3020 Email: igs@berkeley.edu Release # 2017-04 For Publication: Tuesday, April 4, 2017 While Feinstein receives high job marks, voters hold mixed views about whether a re-election bid would be good for the state. Age a factor to some. Governor Brown the leading Democrat for Senate if Feinstein chooses not to run. By Mark DiCamillo, Director, Berkeley IGS Poll (o) 510-642-6835 (c) 415-602-5594 While a large majority of Californians approves of the job that Dianne Feinstein is doing as U.S. Senator, voters offer a mixed assessment when asked whether her seeking a sixth term would be a good thing for the state. In addition, assessments turn negative when reminded that the Senator will be 84 years old next year. Nevertheless, most voters would be inclined to back Feinstein were she to run again. The latest Berkeley IGS Poll finds that 59% of the state’s registered voters view Feinstein’s performance in office positively. However, about half (48%) think that a Feinstein re-election bid in 2018 would be good thing for the state, while 52% feel it would be a bad thing. When voters are reminded of Feinstein’s age, the proportion offering a negative assessment increases to 62%. When asked whether they would support the senior Senator if she were to seek a sixth full term in 2018, 56% say they would. However, this declines slightly to 50% among voters made aware of her age. Preferences are highly partisan, with large majorities of Democrats supportive and about eight in ten Republicans opposed. The poll finds that Governor Jerry Brown, who himself will turn 80 next year, is the Democrat with the highest level of voter support for Senate were Feinstein to choose not to run. In addition, when asked to assess the job that the state’s other U.S. Senator, Kamala Harris, is doing, twice as many voters approve (53%) as disapprove (27%), although 20% are unable to offer an assessment. These results come from a Berkeley IGS Poll conducted online among 1,000 California registered voters in English and Spanish March 13-20.
-
release 2017 04 while Feinstein receives high job marks voters hold mixed views about whether a re election bid would be good for the state age a factor to some governor brown the leading democrat for senate if Feinstein chooses not to run
Berkeley IGS Poll, 2017Co-Authors: Mark DicamilloAbstract:University of California, Berkeley Institute of Governmental Studies 109 Moses Hall, #2370 Berkeley, CA 94720-2370 Tel: 510-642-1473 Fax: 510-642-3020 Email: igs@berkeley.edu Release # 2017-04 For Publication: Tuesday, April 4, 2017 While Feinstein receives high job marks, voters hold mixed views about whether a re-election bid would be good for the state. Age a factor to some. Governor Brown the leading Democrat for Senate if Feinstein chooses not to run. By Mark DiCamillo, Director, Berkeley IGS Poll (o) 510-642-6835 (c) 415-602-5594 While a large majority of Californians approves of the job that Dianne Feinstein is doing as U.S. Senator, voters offer a mixed assessment when asked whether her seeking a sixth term would be a good thing for the state. In addition, assessments turn negative when reminded that the Senator will be 84 years old next year. Nevertheless, most voters would be inclined to back Feinstein were she to run again. The latest Berkeley IGS Poll finds that 59% of the state’s registered voters view Feinstein’s performance in office positively. However, about half (48%) think that a Feinstein re-election bid in 2018 would be good thing for the state, while 52% feel it would be a bad thing. When voters are reminded of Feinstein’s age, the proportion offering a negative assessment increases to 62%. When asked whether they would support the senior Senator if she were to seek a sixth full term in 2018, 56% say they would. However, this declines slightly to 50% among voters made aware of her age. Preferences are highly partisan, with large majorities of Democrats supportive and about eight in ten Republicans opposed. The poll finds that Governor Jerry Brown, who himself will turn 80 next year, is the Democrat with the highest level of voter support for Senate were Feinstein to choose not to run. In addition, when asked to assess the job that the state’s other U.S. Senator, Kamala Harris, is doing, twice as many voters approve (53%) as disapprove (27%), although 20% are unable to offer an assessment. These results come from a Berkeley IGS Poll conducted online among 1,000 California registered voters in English and Spanish March 13-20.
M Husain - One of the best experts on this subject based on the ideXlab platform.
-
Quick cognitive screening for clinicians. Mini mental, clock drawing and other brief tests
Journal of Neurology Neurosurgery and Psychiatry, 2004Co-Authors: M HusainAbstract:K Shulman, and A Feinstein. London: Martin Dunitz, 2003, £34.95, (hardback), pp 176. ISBN 1-84184-239-7 What is the most effective way to screen for cognitive impairment in a busy clinic, or at the bedside? This is a question that most clinicians might contemplate, even if momentarily, in their busy schedules. In this brief text, Shulman and Feinstein take the reader briskly through the …
Olli S. Miettinen - One of the best experts on this subject based on the ideXlab platform.
-
The Epidemiological Interface of Gnostic Clinical Research
Clinical Research Transformed, 2019Co-Authors: Olli S. Miettinen, Johann Steurer, Albert HofmanAbstract:Alvan Feinstein and David Sackett pioneered the now-common tenet that active following and critical evaluation of reports from directly practice-relevant clinical research are integral parts of modern practice of clinical medicine. For this conception of the relation of clinical practice to clinical research – quite questionable – together with their conception of the essence of epidemiology – mistaken – Feinstein and Sackett adopted the term ‘clinical epidemiology’ – a contradiction in terms. Feinstein was very hesitant about accepting this term – exogenous to him – for the statistical-type clinical research he was concerned with (and called clinimetrics); and he didn’t attempt to define the concept. We here, apart from describing the genesis of and thinking about this contemporary version of ‘clinical epidemiology,’ outline the actual nature of the interface of gnostic clinical research with epidemiology, which implies that gnostic clinical research is neither epidemiology nor epidemiological research – but: meta-epidemiological clinical research.
-
Feinstein and study design.
Journal of Clinical Epidemiology, 2002Co-Authors: Olli S. MiettinenAbstract:Abstract Dr. Alvan Feinstein saw himself as the father of “clinical epidemiology” in the modern meaning of this term, of this “new intellectual domain of modern medical science.” In this role, he saw himself as drawing from his “clinical sophistication” and from “the rigorous scientific demands” to which “clinicians are accustomed,” while “public health” epidemiologists “often use a more arbitrary set of standards.” His conception of the scope of clinical epidemiology was remarkably Catholic and the same was the case in respect to cause-effect research in it. In the latter, he was firmly committed to the randomized-trial paradigm, including in his teachings on study design in etiologic research. Characteristically original, many of Dr. Feinstein's study-design ideas remain controversial.
Sidney Weinstein - One of the best experts on this subject based on the ideXlab platform.
-
fifty years of somatosensory research from the semmes weinstein monofilaments to the weinstein enhanced sensory test
Journal of Hand Therapy, 1993Co-Authors: Sidney WeinsteinAbstract:Abstract In this paper, the author's long history with somatosensation is overviewed with special emphasis on the creation of objective tests of sensibility. Objective testing is discussed using numerous examples from the author's experiences. The creation of the Semmes-Weinstein monofilaments is discussed. Tests employing the Semmes-Weinstein monofilaments, two-point discrimination, and point localization are discussed with reference to the fact that these tests reflect specific differences between the central and peripheral nervous systems. Towards that end, contrasts are made between the Semmes-Weinstein esthesiometer and both the two-point discrimination and the point-localization tests. A new enhancement of the original Semmes-Weinstein monofilament test, the Weinstein Enhanced Sensory Test * (WEST * ), is introduced. Advantages of the WEST are discussed.
